213 related articles for article (PubMed ID: 30477803)
1. Contrast-Induced Nephropathy and Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention in Patients With Advanced Renal Dysfunction (Estimated Glomerular Filtration Rate <30 ml/min/1.73 m
Negishi Y; Tanaka A; Ishii H; Takagi K; Inoue Y; Uemura Y; Umemoto N; Yoshioka N; Morishima I; Asano H; Watarai M; Shibata N; Suzuki S; Murohara T
Am J Cardiol; 2019 Feb; 123(3):361-367. PubMed ID: 30477803
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
3. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
4. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
[TBL] [Abstract][Full Text] [Related]
5. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
6. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography.
Chen SQ; Liu Y; Smyth B; Li HL; Sun GL; Chen ZJ; Zhou YL
Heart Lung Circ; 2019 Jun; 28(6):866-873. PubMed ID: 29960836
[TBL] [Abstract][Full Text] [Related]
8. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
[TBL] [Abstract][Full Text] [Related]
11. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
Liu YH; Liu Y; Tan N; Chen JY; Zhou YL; Luo JF; Yu DQ; Li LW; Li HL; Ye P; Ran P
Eur Radiol; 2015 Aug; 25(8):2274-81. PubMed ID: 25981215
[TBL] [Abstract][Full Text] [Related]
13. Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
Kurogi K; Ishii M; Sakamoto K; Komaki S; Marume K; Kusaka H; Yamamoto N; Arima Y; Yamamoto E; Kaikita K; Tsujita K
J Am Heart Assoc; 2019 Dec; 8(23):e014096. PubMed ID: 31766973
[TBL] [Abstract][Full Text] [Related]
14. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.
Cui T; Zhao J; Bei W; Li H; Tan N; Wu D; Wang K; Guo X; Liu Y; Duan C; Chen S; Lin K; Liu Y
Cardiol J; 2017; 24(6):660-670. PubMed ID: 28394010
[TBL] [Abstract][Full Text] [Related]
15. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
17. CKD-EPI versus Cockcroft-Gault formula for predicting contrast-induced nephropathy following percutaneous coronary intervention in patients without significant renal impairment.
Nunes MBG; Filho AC; Alvares VRC; Meneguz-Moreno R; Lamas E; Loures V; Chamié D; Abizaid A
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):25-33. PubMed ID: 29352692
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
20. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
